Mother Tincture
Tincture of the whole Scutellaria lateriflora plant, used at practitioner-directed dilution.
Mother Tincture · Whole Plant
Not Listed Fr. Pharmacopoeia · Lamiaceae
Biological Overview
Scutellaria lateriflora is a herbaceous plant native to North America, belonging to the mint family. It is harvested for medicinal use from the aerial parts of plants that are two to three years old, and has a long ethnobotanical history among Native American peoples, including the Cherokee.
HabitHerbaceous Perennial
Native RangeNorth America
Baicalin Content~4% (aerial parts)
Regulatory StatusNot on Fr. Pharmacopoeia List A*
Botanical Classification
Taxonomy & Identification
- Latin Name
- Scutellaria lateriflora L.
- Family
- Lamiaceae
- Common Names
- American Skullcap, Scullcap, Blue Skullcap
- Parts Used
- Aerial parts (2–3 year old plants)
- Related Species
- Scutellaria baicalensis (Chinese skullcap — different plant)
- Origin
- Native to North America
*Only Scutellaria baicalensis root is listed on the French Pharmacopoeia's List A, reflecting its traditional Chinese medicine use — not S. lateriflora itself.
Ethnobotany & Traditional Use
History & Tradition
American skullcap has deep roots in Native American ethnobotanical medicine and has long been used in North American folk medicine as an anxiolytic. Its aerial parts are reported to have been used by Native American peoples during purification rites.
Native American use centered on its properties as a calmative, sedative, and nervous-system tonic — to promote sleep, calm episodes of hysteria and epileptic convulsions, and address various other neurological complaints. Scutellaria lateriflora was specifically used by the Cherokee. 1
Later, reports of hepatotoxicity associated with skullcap products raised safety concerns — but these cases were subsequently traced to germander (Teucrium chamaedrys) contamination or substitution rather than to genuine Scutellaria lateriflora. 20
⚠ Adulteration History
Historically reported hepatotoxicity cases linked to skullcap have been traced to germander (Teucrium chamaedrys) adulteration, not genuine skullcap. Chromatographic analysis reliably distinguishes authentic Scutellaria lateriflora from Teucrium adulterants. 21
The Key Molecule
Baicalin & Baicalein — Deep Dive
The dominant flavonoid and its aglycone behind American skullcap's calming, neuroprotective, and analgesic research.
🧬
Dominant Flavonoid Pair
Baicalin (~4%) and its aglycone baicalein (~3.3%) are the dominant flavonoids in American skullcap, alongside scutellarin, scutellareine, wogonin, and related compounds.
🧠
GABA-A Receptor Modulation
Skullcap's sedative properties are linked to activity at the GABA-A receptor. 8
🛡️
🔬
Alpha-Synuclein Aggregation Inhibition
Baicalein and scutellareine inhibit formation of alpha-synuclein oligomers in vivo, a mechanism explored for potential relevance to Parkinson's disease. 13
⚠ A Dual Calming Mechanism
Skullcap contains GABA itself, not just compounds that act on GABA receptors.
American skullcap contains a small but measurable amount of GABA directly (roughly 0.16%), in addition to flavonoids that modulate the GABA-A receptor — a dual mechanism relatively unusual among calming botanicals.
Pharmaceutical Preparations
Parts Used & Available Forms
The aerial parts are the only part used medicinally. Only one standardized form is documented in the available phytotherapy literature.
Clinical Dosimetry
Dosages
No standardized usual dosage is established in the available phytotherapy literature for American skullcap. The one concrete data point comes from a controlled clinical trial, reflected below as a research dose rather than general guidance.
Phytochemistry
Composition
Aerial-part and essential-oil composition only — no gemmotherapy (bud) fraction is documented for this species.
Aerial Parts — Primary Constituents
BaicalinDominant flavonoid glycoside, primary marker compound
~4%
BaicaleinAglycone of baicalin
~3.3%
Other FlavonoidsScutellarin, scutellareine, wogonin, lateriflorin, ikonnikoside I, oroxylin A, genkwanin, hesperetin, quercetin, rutin, naringenin, chrysin, daidzein
Present
GABAPresent directly in the plant, in addition to GABA-A receptor-active flavonoids
~0.16%
Tannins & PolysaccharidesStructural and minor bioactive constituents
Present
Glutamine & Ascorbic AcidMinor constituents
Present
Essential Oil — Primary Constituents
alpha-CubebeneSesquiterpene
Present
alpha-HumuleneSesquiterpene
Present
beta-ElemeneSesquiterpene
Present
CalameneneSesquiterpene
Present
delta-CadineneSesquiterpene
Present
🧠
Anxiolytic
Multiple systematic reviews and controlled trials support an anxiolytic effect, including a randomized crossover study in healthy volunteers. 236
😴
Sedative
Sedative activity is linked to effects on the GABA-A receptor. 78
🌙
Sleep-Promoting
A controlled trial using 400 mg of skullcap extract orally found improved sleep induction and sleep quality. 9
🛡️
Neuroprotective
Shows antidepressant-like and neuroprotective potential, stimulating neurogenesis and neurotrophic factor synthesis while countering oxidative stress. 10111213
💊
Analgesic
Documented analgesic activity, including in pain related to bone metastases. 141516
💪
Muscle Relaxant
Traditionally regarded as a muscle relaxant, consistent with its use for muscle tension.
🧫
Anti-Prion
Inhibits development of prion-related disease processes in animal models. 18
🔗
Serotonin Receptor Affinity
Flavonoids in skullcap show affinity for serotonin receptors, a mechanism proposed to contribute to mood-related effects. 17
Clinical Applications
Clinical Indications
American skullcap's primary use is anxiety and nervous tension, with additional research interest in sleep and neurodegenerative disease.
🧠
Anxiety & Nervous Tension
Primary Indication
- Anxiety & Depressive States: Traditionally and clinically used for anxiety, depressive states, muscle tension, and nervous fatigue.
😴
Sleep Support
Research-Backed Indication
- Sleep Induction & Quality: A controlled crossover trial found improved sleep induction and sleep quality with 400 mg of oral extract. 9
🧬
Neurodegenerative Research
Preliminary Interest
- Parkinson's Disease (Preliminary): Explored in neurodegenerative disease contexts, including Parkinson's disease — flagged as tentative in the source literature itself. 19
⚠️
Use Considerations
Clinical Precautions
- Product Identity Matters: Hepatotoxicity concerns are linked to germander adulteration, not genuine skullcap. 20
- Not Interchangeable with Chinese Skullcap: France restricts official pharmacopoeia listing to Scutellaria baicalensis root (TCM use), a different species from S. lateriflora.
Pharmacodynamics
Mode of Action
American skullcap's calming and neuroprotective effects converge on receptor-level activity and broader neurological support pathways.
🧠
GABA-A Receptor Activity
Skullcap's calming and sedative properties are linked to modulation of the GABA-A receptor. 8
🔗
Serotonin Receptor Affinity
Flavonoids in skullcap show affinity for serotonin receptors, a mechanism proposed to contribute to its mood-related effects. 17
🛡️
Mitochondrial & Neurotrophic Support
Neuroprotective and antidepressant-like potential is linked to stimulated neurogenesis, increased neurotrophic factor synthesis, and reduced oxidative stress, mitochondrial dysfunction, and inflammation. 10
🔬
Alpha-Synuclein Aggregation Inhibition
Baicalein and scutellareine inhibit formation of alpha-synuclein oligomers in vivo, a mechanism explored for Parkinson's disease. 13
Comparative Analysis
American Skullcap vs Valerian
Two traditional nervous-system botanicals that serve different moments in the day rather than directly competing.
Bottom Line
American skullcap and valerian are both traditional nervous-system botanicals, but they tend to serve different moments — skullcap is often used for daytime anxiety and nervous tension without heavy sedation, while valerian is more specifically used to support sleep onset at night. Product quality matters more for skullcap than for most herbs, given its documented history of germander adulteration.
Risk Profile
Safety & Interactions
American skullcap's safety profile centers on product authenticity — genuine skullcap has a comparatively mild history once germander adulteration is ruled out.
⚠ Genuine Risks Specific to This Plant
Read Before Using American Skullcap
- Adulteration-related hepatotoxicity: reported cases of hepatotoxicity attributed to skullcap products have been traced to contamination or substitution with germander (Teucrium chamaedrys), not genuine Scutellaria lateriflora. 20
- Species identity confirmation matters: chromatographic analysis is required to reliably distinguish genuine S. lateriflora from Teucrium canadense or T. chamaedrys adulterants. 21
- Not equivalent to Chinese skullcap: Scutellaria baicalensis is a different plant with its own distinct regulatory status and traditional use pattern — don't conflate the two.
- Possible high-dose euphoric effects: reported anecdotally at high doses, though this effect is not well confirmed in the available literature.
✓ How to Use American Skullcap More Safely
A Practical Safety Checklist
- Buy from a verified source. Given the germander-adulteration history, choose products that confirm species identity and third-party testing.
- Know which skullcap you're taking. American skullcap and Chinese skullcap are different plants used differently — check the label.
- Start with a lower dose to assess your sensitivity, especially given anecdotal reports of euphoric effects at high doses.
- Watch your liver health if using long-term or alongside other hepatoactive substances, given the historical hepatotoxicity association (even though traced to adulterants).
- Avoid combining with other sedatives without medical guidance, given skullcap's own GABA-A activity.
- Talk to a provider first if pregnant, breastfeeding, or on neurological or psychiatric medication.
Adverse Effects
- Hepatotoxicity (Adulteration-Linked): suspected hepatotoxicity in historical case reports is attributed to germander-contaminated products rather than genuine skullcap. 20
- Possible High-Dose Euphoria: anecdotally reported at high doses, though this effect is not well confirmed.
Contraindications & Interactions
- Sedative Combinations: use caution when combining with other sedative or GABA-ergic substances, given skullcap's own GABA-A receptor activity.
- Product Identity: verify species and sourcing given the historical germander-adulteration issue; chromatographic verification reliably confirms authenticity. 21
- Regulatory Note: only Scutellaria baicalensis root (a different species, used in Traditional Chinese Medicine) is listed on the French Pharmacopoeia's List A — S. lateriflora itself is not.
Clinical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare provider before starting American skullcap, particularly if pregnant, breastfeeding, or taking sedative or psychiatric medication.
Common Questions
Frequently Asked Questions
What is American skullcap used for?
American skullcap is traditionally used for anxiety, depressive states, muscle tension, and nervous fatigue, and has been studied for sleep support.
How does American skullcap work for anxiety?
Its flavonoids, particularly baicalin and baicalein, are linked to activity at the GABA-A receptor and show affinity for serotonin receptors, mechanisms thought to underlie its calming and mood-related effects. The plant also contains a small amount of GABA itself.
Is American skullcap the same as Chinese skullcap?
No. American skullcap (Scutellaria lateriflora) and Chinese skullcap (Scutellaria baicalensis) are different species used differently — only the Chinese skullcap root is listed on the French Pharmacopoeia's List A, reflecting its use in traditional Chinese medicine.
What is the typical American skullcap dosage?
No standardized usual dosage is established in the available phytotherapy literature. A clinical trial on sleep quality used 400 mg of skullcap extract taken orally, but this reflects a research protocol rather than general dosing guidance.
Is American skullcap safe for the liver?
Historical reports of hepatotoxicity linked to skullcap products have been traced to contamination or substitution with germander (Teucrium chamaedrys) rather than genuine Scutellaria lateriflora, which is why sourcing and species verification matter for this herb.
Can I take American skullcap with other calming supplements?
Use caution. Because skullcap has its own GABA-A receptor activity, combining it with other sedative or GABA-ergic supplements or medications without medical guidance is not recommended.
Does American skullcap help with sleep?
A randomized, controlled, crossover clinical trial found that 400 mg of a chemically characterized Scutellaria lateriflora extract improved sleep quality and had a sleep-inducing effect.
Is American skullcap better than valerian?
They serve somewhat different purposes: skullcap is more often used for daytime anxiety and nervous tension without heavy sedation, while valerian is more specifically used to support sleep onset at night.
Sources
Bibliography
1. Setzer WN. The phytochemistry of Cherokee aromatic medicinal plants. Medicines (Basel). 2018;5(4):121.
PubMed: PMID 30424560 →↩
PubMed: PMID 30424560 →↩
2. Sarris J. Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytother Res. 2007;21(8):703–716.
PubMed: PMID 17562566 →↩
PubMed: PMID 17562566 →↩
3. Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21(12):841–860.
PubMed: PMID 21601431 →↩
PubMed: PMID 21601431 →↩
4. Alramadhan E, Hanna MS, Hanna MS, Goldstein TA, Avila SM, Weeks BS. Dietary and botanical anxiolytics. Med Sci Monit. 2012;18(4):RA40–RA48.
Full Text (PMC) →
Full Text (PMC) →
5. Wolfson P, Hoffmann DL. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med. 2003;9(2):74–78.
PubMed: PMID 12652886 →
PubMed: PMID 12652886 →
6. Brock C, Whitehouse J, Tewfik I, Towell T. American skullcap (Scutellaria lateriflora): a randomised, double-blind placebo-controlled crossover study of its effects on mood in healthy volunteers. Phytother Res. 2014;28(5):692–698.
PubMed: PMID 23878109 →↩
PubMed: PMID 23878109 →↩
7. Upton R, DAyu RH. Skullcap Scutellaria lateriflora L.: an American nervine. J Herb Med. 2012;2(3):76–96.
DOI: 10.1016/j.hermed.2012.06.004 →↩
DOI: 10.1016/j.hermed.2012.06.004 →↩
8. Awad R, Arnason JT, et al. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine. 2003;10(8):640–649.
PubMed: PMID 14692724 →↩
PubMed: PMID 14692724 →↩
9. Di Minno A, Morone MV, Buccato DG, et al. Efficacy and tolerability of a chemically characterized Scutellaria lateriflora L. extract-based food supplement for sleep management: a single-center, controlled, randomized, crossover, double-blind clinical trial. Nutrients. 2025;17(9):1491.
DOI: 10.3390/nu17091491 →↩
DOI: 10.3390/nu17091491 →↩
10. Limanaqi F, Biagioni F, Busceti CL, Polzella M, Fabrizi C, Fornai F. Potential antidepressant effects of Scutellaria baicalensis, Hericium erinaceus and Rhodiola rosea. Antioxidants (Basel). 2020;9(3):234.
PubMed: PMID 32178272 →↩
PubMed: PMID 32178272 →↩
11. Lohani M, Ahuja M, Buabeid MA, et al. Anti-oxidative and DNA protecting effects of flavonoids-rich Scutellaria lateriflora. Nat Prod Commun. 2013;8(10):1415–1418.
PubMed: PMID 24354189 →↩
PubMed: PMID 24354189 →↩
12. de Oliveira MR, Nabavi SF, Habtemariam S, Erdogan Orhan I, Daglia M, Nabavi SM. The effects of baicalein and baicalin on mitochondrial function and dynamics: a review. Pharmacol Res. 2015;100:296–308.
PubMed: PMID 26318266 →↩
PubMed: PMID 26318266 →↩
13. Caruana M, Högen T, Levin J, Hillmer A, Giese A, Vassallo N. Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds. FEBS Lett. 2011;585(8):1113–1120.
PubMed: PMID 21443877 →↩
PubMed: PMID 21443877 →↩
14. Uritu CM, Mihai CT, Stanciu GD, et al. Medicinal plants of the family Lamiaceae in pain therapy: a review. Pain Res Manag. 2018;2018:7801543.
PubMed: PMID 29854039 →↩
PubMed: PMID 29854039 →↩
15. Hu S, Chen Y, Wang ZF, et al. The analgesic and antineuroinflammatory effect of baicalein in cancer-induced bone pain. Evid Based Complement Alternat Med. 2015;2015:973524.
PubMed: PMID 26649065 →↩
PubMed: PMID 26649065 →↩
16. Cherng CH, Lee KC, Chien CC, et al. Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation rats. J Formos Med Assoc. 2014;113(8):513–520.
PubMed: PMID 23684218 →↩
PubMed: PMID 23684218 →↩
17. Brock C, Whitehouse J, Tewfik I, Towell T. American skullcap (Scutellaria lateriflora): an ancient remedy for today's anxiety? Br J Wellbeing. 2010;1(4):25–30.↩
18. Eiden M, Leidel F, Strohmeier B, Fast C, Groschup MH. A medicinal herb Scutellaria lateriflora inhibits PrP replication in vitro and delays the onset of prion disease in mice. Front Psychiatry. 2012;3:9.
PubMed: PMID 22363300 →↩
PubMed: PMID 22363300 →↩
19. Mazio E. Comprehensive nutraceutical agent for treatment/prevention of Parkinson's disease. US Patent Application Publication No. US2007/0116779A1, May 24, 2007.
Patent Document →↩
Patent Document →↩
20. Upton R, DAyu RH. Skullcap Scutellaria lateriflora L.: an American nervine. J Herb Med. 2012;2(3):76–96. (Same source as ref. 7, cited separately by Wikiphyto for its adulteration discussion.)↩
21. Lin LZ, Harnly JM, Upton R. Comparison of the phenolic component profiles of skullcap (Scutellaria lateriflora) and germander (Teucrium canadense and T. chamaedrys), a potentially hepatotoxic adulterant. Phytochem Anal. 2009;20(4):298–306.
DOI: 10.1002/pca.1127 →↩
DOI: 10.1002/pca.1127 →↩
Additional Sources
Nishikawa K, Furukawa H, Fujioka T, Fujii H, Mihashi K, Shimomura K, Ishimaru K. Phenolics in tissue cultures of Scutellaria. Recent Res Dev Phytochem. 2000;4:55–60.